A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Clinical trial NCT05262010 · RECRUITING

Trial details

NCT number: NCT05262010
Sponsor: National Vaccine and Serum Institute, China
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HPV InfectioN HPV-Related Carcinoma

Start date: 2022-06-04
Primary completion: 2028-06-01
Enrollment: 13500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.